On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini. This instrumentation change is necessary as Bio-Rad is discontinuing service on our existing QuickStep instrumentation.
Although the Immucor assay and sample requirements will remain the same, the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list will be available on the CTS website on 04/29/19.
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...